E-resources
-
Vitiello, Marianna; Tuccoli, Andrea; D'Aurizio, Romina; Sarti, Samanta; Giannecchini, Laura; Lubrano, Simone; Marranci, Andrea; Evangelista, Monica; Peppicelli, Silvia; Ippolito, Chiara; Barravecchia, Ivana; Guzzolino, Elena; Montagnani, Valentina; Gowen, Michael; Mercoledi, Elisa; Mercatanti, Alberto; Comelli, Laura; Gurrieri, Salvatore; Wu, Lawrence W; Ope, Omotayo; Flaherty, Keith; Boland, Genevieve M; Hammond, Marc R; Kwong, Lawrence; Chiariello, Mario; Stecca, Barbara; Zhang, Gao; Salvetti, Alessandra; Angeloni, Debora; Pitto, Letizia; Calorini, Lido; Chiorino, Giovanna; Pellegrini, Marco; Herlyn, Meenhard; Osman, Iman; Poliseno, Laura
Oncotarget, 04/2017, Volume: 8, Issue: 15Journal Article
Despite increasing amounts of experimental evidence depicting the involvement of non-coding RNAs in cancer, the study of BRAFV600E-regulated genes has thus far focused mainly on protein-coding ones. Here, we identify and study the microRNAs that BRAFV600E regulates through the ERK pathway.By performing small RNA sequencing on A375 melanoma cells and a vemurafenib-resistant clone that was taken as negative control, we discover miR-204 and miR-211 as the miRNAs most induced by vemurafenib. We also demonstrate that, although belonging to the same family, these two miRNAs have distinctive features. miR-204 is under the control of STAT3 and its expression is induced in amelanotic melanoma cells, where it acts as an effector of vemurafenib's anti-motility activity by targeting AP1S2. Conversely, miR-211, a known transcriptional target of MITF, is induced in melanotic melanoma cells, where it targets EDEM1 and consequently impairs the degradation of TYROSINASE (TYR) through the ER-associated degradation (ERAD) pathway. In doing so, miR-211 serves as an effector of vemurafenib's pro-pigmentation activity. We also show that such an increase in pigmentation in turn represents an adaptive response that needs to be overcome using appropriate inhibitors in order to increase the efficacy of vemurafenib.In summary, we unveil the distinct and context-dependent activities exerted by miR-204 family members in melanoma cells. Our work challenges the widely accepted "same miRNA family = same function" rule and provides a rationale for a novel treatment strategy for melanotic melanomas that is based on the combination of ERK pathway inhibitors with pigmentation inhibitors.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.